These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 17059941)
21. Metastasis models: the green fluorescent revolution? Paris S; Sesboüé R Carcinogenesis; 2004 Dec; 25(12):2285-92. PubMed ID: 15217904 [TBL] [Abstract][Full Text] [Related]
22. Oncolytic viral therapy for cervical and ovarian cancer cells by Sindbis virus AR339 strain. Unno Y; Shino Y; Kondo F; Igarashi N; Wang G; Shimura R; Yamaguchi T; Asano T; Saisho H; Sekiya S; Shirasawa H Clin Cancer Res; 2005 Jun; 11(12):4553-60. PubMed ID: 15958641 [TBL] [Abstract][Full Text] [Related]
23. Real-time whole-body imaging of an orthotopic metastatic prostate cancer model expressing red fluorescent protein. Yang M; Jiang P; Yamamoto N; Li L; Geller J; Moossa AR; Hoffman RM Prostate; 2005 Mar; 62(4):374-9. PubMed ID: 15389802 [TBL] [Abstract][Full Text] [Related]
24. Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide. Aghi M; Rabkin SD; Martuza RL Cancer Res; 2007 Jan; 67(2):440-4. PubMed ID: 17234749 [TBL] [Abstract][Full Text] [Related]
25. Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels. Hayashi K; Jiang P; Yamauchi K; Yamamoto N; Tsuchiya H; Tomita K; Moossa AR; Bouvet M; Hoffman RM Cancer Res; 2007 Sep; 67(17):8223-8. PubMed ID: 17804736 [TBL] [Abstract][Full Text] [Related]
26. Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses. Adusumilli PS; Stiles BM; Chan MK; Mullerad M; Eisenberg DP; Ben-Porat L; Huq R; Rusch VW; Fong Y J Gene Med; 2006 May; 8(5):603-15. PubMed ID: 16475242 [TBL] [Abstract][Full Text] [Related]
27. Factors that limit the effectiveness of herpes simplex virus type 1 for treatment of oral cancer in mice. Shillitoe EJ; Pellenz C Clin Cancer Res; 2005 Apr; 11(8):3109-16. PubMed ID: 15837767 [TBL] [Abstract][Full Text] [Related]
28. Adenovirus replication-competent vectors (KD1, KD3) complement the cytotoxicity and transgene expression from replication-defective vectors (Ad-GFP, Ad-Luc). Habib NA; Mitry R; Seth P; Kuppuswamy M; Doronin K; Toth K; Krajcsi P; Tollefson AE; Wold WS Cancer Gene Ther; 2002 Aug; 9(8):651-4. PubMed ID: 12136425 [TBL] [Abstract][Full Text] [Related]
29. [Fluorescent imaging of angiogenesis and spontaneous metastasis in transplanted hepatoma: experiment with mice]. Wang Y; Feng GS; Tian H; Zhang ZH; Xiong T Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3307-9. PubMed ID: 18396632 [TBL] [Abstract][Full Text] [Related]
30. Splenic, thymic, bony and lymph node metastases from orthotopic human lung carcinomas in immunocompromised mice. Hastings RH; Burton DW; Summers-Torres D; Quintana R; Biederman E; Deftos LJ Anticancer Res; 2000; 20(5B):3625-9. PubMed ID: 11131672 [TBL] [Abstract][Full Text] [Related]
31. The use of green fluorescent fusion proteins to monitor herpes simplex virus replication. Taylor TJ; Knipe DM Methods Mol Biol; 2009; 515():239-48. PubMed ID: 19378129 [TBL] [Abstract][Full Text] [Related]
32. Fluorescence-expressing viruses allow rapid identification and separation of rare tumor cells in spiked samples of human whole blood. Fong SM; Lee MK; Adusumilli PS; Kelly KJ Surgery; 2009 Sep; 146(3):498-505. PubMed ID: 19715807 [TBL] [Abstract][Full Text] [Related]
33. Visualization of the metastatic process by green fluorescent protein expression. Chishima T; Miyagi Y; Wang X; Tan Y; Shimada H; Moossa A; Hoffman RM Anticancer Res; 1997; 17(4A):2377-84. PubMed ID: 9252650 [TBL] [Abstract][Full Text] [Related]
34. Extension of survival by resection of asynchronous renal cell carcinoma metastases to mediastinal lymph nodes. Whitson BA; Groth SS; Andrade RS; Garrett L; Dudek AZ; Jessurun J; Maddaus MA J Thorac Cardiovasc Surg; 2008 May; 135(5):1022-8. PubMed ID: 18455579 [TBL] [Abstract][Full Text] [Related]
35. Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10. Watanabe D; Goshima F; Mori I; Tamada Y; Matsumoto Y; Nishiyama Y J Dermatol Sci; 2008 Jun; 50(3):185-96. PubMed ID: 18226503 [TBL] [Abstract][Full Text] [Related]
36. Gene expression in early stage cervical cancer. Biewenga P; Buist MR; Moerland PD; Ver Loren van Themaat E; van Kampen AH; ten Kate FJ; Baas F Gynecol Oncol; 2008 Mar; 108(3):520-6. PubMed ID: 18191186 [TBL] [Abstract][Full Text] [Related]
37. Utility of TK/GCV in the context of highly effective oncolysis mediated by a serotype 3 receptor targeted oncolytic adenovirus. Raki M; Hakkarainen T; Bauerschmitz GJ; Särkioja M; Desmond RA; Kanerva A; Hemminki A Gene Ther; 2007 Oct; 14(19):1380-8. PubMed ID: 17611584 [TBL] [Abstract][Full Text] [Related]
38. An HSV-1 amplicon system for prostate-specific expression of ICP4 to complement oncolytic viral replication for in vitro and in vivo treatment of prostate cancer cells. Lee CY; Bu LX; Rennie PS; Jia WW Cancer Gene Ther; 2007 Jul; 14(7):652-60. PubMed ID: 17479106 [TBL] [Abstract][Full Text] [Related]
39. Telomerase-specific virotheranostics for human head and neck cancer. Kurihara Y; Watanabe Y; Onimatsu H; Kojima T; Shirota T; Hatori M; Liu D; Kyo S; Mizuguchi H; Urata Y; Shintani S; Fujiwara T Clin Cancer Res; 2009 Apr; 15(7):2335-43. PubMed ID: 19318473 [TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer. Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]